Buspirone

Brand Name: BuSpar is the best-known historical brand name for buspirone. The original BuSpar product is no longer marketed in Canada or the United States, but generic buspirone remains available. Current Canadian products include AMB-Buspirone, Auro-Buspirone, PMS-Buspirone, Pro-Buspirone and Teva-Buspirone.

Other international brand names: Buspin, Buscalm, Spitomin, Anksilon, Ansial, Ansitec, Anxiolan, Bespar, Buspon and others. Brand availability varies by country.

What You Need to Know

Buspirone is a non-benzodiazepine anti-anxiety medication used primarily to treat generalized anxiety disorder (GAD). It belongs to a group of medications called anxiolytics.

Buspirone works differently from benzodiazepines such as lorazepam, clonazepam or alprazolam. It does not primarily act through the brain’s GABA system and generally does not produce the same degree of sedation, intoxication, tolerance or physical dependence associated with benzodiazepines.

Instead, buspirone primarily affects serotonin signaling, particularly the: 5-HT1A serotonin receptor

Buspirone also has some activity involving dopamine D2 receptors and other neurotransmitter systems, although the exact way in which these actions relieve anxiety is not completely understood.

Unlike medications used for immediate relief of acute anxiety, buspirone generally needs to be taken regularly every day, and its benefits develop gradually.

What Is Buspirone Used For?

Buspirone is primarily prescribed for:

Generalized Anxiety Disorder — GAD

Symptoms of GAD can include:

• Persistent worry
• Feeling tense or “on edge”
• Difficulty relaxing
• Irritability
• Restlessness
• Difficulty concentrating
• Muscle tension
• Sleep disturbance
• Physical symptoms of anxiety Canadian prescribing information indicates buspirone for the short-term relief of anxiety symptoms in adults with generalized anxiety disorder.

Buspirone may also be prescribed off label in selected patients for other psychiatric situations, including as an adjunct to other medications, but these uses should be individualized by the treating healthcare professional.

How Is Buspirone Different from Benzodiazepines?

Buspirone and benzodiazepines can both be used for anxiety, but their mechanisms and clinical profiles are very different.

Benzodiazepines

primarily enhance:

1. GABA signaling
2. which can rapidly reduce nervous-system activity.

This can produce relatively rapid:

• Anxiety relief

• Sedation

• Muscle relaxation but can also lead to:

• Tolerance

• Physical dependence

• Withdrawal

• Cognitive impairment in some patients Buspirone

primarily affects:

1. 5-HT1A serotonin signaling
2. and produces a gradual anti-anxiety effect.

Buspirone generally has much less potential for:

• Sedation
• Intoxication
• Abuse
• Physical dependence Buspirone is not a substitute for a benzodiazepine when someone is already physically dependent on a benzodiazepine because it does not prevent benzodiazepine withdrawal.

How Long Does Buspirone Take to Work?

Buspirone is not an immediate-relief anxiety medication. Some people begin noticing improvement after approximately 1–2 weeks, but more substantial benefit may take several weeks.

It therefore needs to be taken consistently rather than only when anxiety occurs.

MedlinePlus notes that the dose is commonly increased gradually and that it may take several weeks to reach an effective dose and response.

What Are the Common Side Effects of Buspirone?

Common side effects can include:

• Dizziness
• Nausea
• Headache
• Lightheadedness
• Nervousness
• Restlessness
• Excitement
• Fatigue
• Weakness
• Difficulty sleeping
• Diarrhea
• Drowsiness in some people
• Numbness or tingling Dizziness is one of the more commonly reported effects.

Some side effects may improve as the body adjusts to treatment.

Buspirone affects serotonin signaling.

When combined with other medications that increase serotonin, there is a risk—usually uncommon—of serotonin syndrome.

Symptoms can include:

• Agitation
• Confusion
• Sweating
• Fever
• Rapid heart rate
• Changes in blood pressure
• Tremor
• Muscle rigidity
• Muscle twitching
• Overactive reflexes
• Diarrhea
• Nausea or vomiting Severe serotonin syndrome is a medical emergency.

Dizziness and Driving

Buspirone is generally less sedating than benzodiazepines, but individual reactions vary.

Until a person knows how buspirone affects them, caution should be used with:

• Driving
• Operating machinery
• Other activities requiring alertness The prescribing information specifically recommends assessing individual response before performing potentially hazardous activities.

Liver and Kidney Function

Buspirone is extensively metabolized by the liver.

Drug exposure can become substantially higher in people with significant:

• Liver impairment
• Kidney impairment In pharmacokinetic studies, buspirone exposure was approximately 13-fold higher with hepatic impairment and approximately 4-fold higher with renal impairment.

Canadian prescribing information advises against use in people with severe liver or kidney impairment.

Drug Interactions

Drug interactions are particularly important with buspirone because the medication is metabolized primarily by: CYP3A4

Medications that inhibit CYP3A4 can greatly increase buspirone concentrations.

Medications that induce CYP3A4 can substantially decrease buspirone concentrations.

MAO Inhibitors — Contraindicated

Examples include:

• Phenelzine
• Tranylcypromine
• Isocarboxazid
• Linezolid
• Intravenous methylene blue
• Certain uses of selegiline Buspirone should generally not be taken with an MAOI or within 14 days of an MAOI used to treat depression.

The combination can increase the risk of:

• Serotonin syndrome
• Dangerously elevated blood pressure A 14-day separation is also required in the other direction when starting an MAOI after buspirone.

SSRIs and SNRIs

Examples include:

• Sertraline
• Escitalopram
• Fluoxetine
• Paroxetine
• Venlafaxine
• Desvenlafaxine
• Duloxetine Buspirone is sometimes intentionally combined with antidepressants.

However, because both medications can affect serotonin, the combination can increase serotonergic activity.

Patients should therefore be monitored for symptoms of serotonin syndrome, particularly after treatment begins or doses are increased.

The combination is not automatically contraindicated; it is commonly used clinically when appropriate.

Other Serotonergic Medications

Additional medications or substances that can increase serotonin include:

• Tramadol
• Triptans used for migraine
• Some opioid medications
• Lithium
• Tryptophan supplements
• St. John’s Wort Combining multiple serotonergic medications may increase the risk of serotonin toxicity.

Erythromycin — CYP3A4 Inhibitor

Erythromycin can strongly reduce buspirone metabolism.

In a clinical interaction study:

1. Erythromycin
2. CYP3A4 inhibition
3. Buspirone metabolism decreases
4. Buspirone exposure increased approximately six-fold

The prescribing information recommends using a much lower buspirone dose if the combination is necessary.

Itraconazole and Other Strong CYP3A4 Inhibitors

Itraconazole is a particularly strong CYP3A4 inhibitor.

In one interaction study it increased buspirone:

• Peak concentration approximately 13-fold
• Overall exposure approximately 19-fold This can greatly increase the likelihood of buspirone-related adverse effects.

Other strong CYP3A4 inhibitors can include medications such as:

• Ketoconazole
• Ritonavir
• Certain other antiviral medications Dose reduction or another medication may be necessary.

Verapamil and Diltiazem

Both medications inhibit CYP3A4 to some degree.

Clinical studies found:

Verapamil → buspirone exposure increased approximately 3.4-fold

and

Diltiazem → buspirone exposure increased approximately 5.5-fold

Greater exposure can increase dizziness and other buspirone side effects.

Grapefruit and Grapefruit Juice

Grapefruit can inhibit intestinal CYP3A4 and substantially increase buspirone exposure.

In a study involving large amounts of grapefruit juice:

Buspirone peak concentration increased approximately 4-fold

and

overall exposure increased approximately 9-fold.

Patients taking buspirone are therefore advised to avoid large amounts of grapefruit or grapefruit juice.

Rifampin — CYP3A4 Inducer

Rifampin has the opposite effect.

It strongly increases CYP3A4 activity.

Therefore:

1. Rifampin
2. CYP3A4 activity increases
3. Buspirone metabolism increases
4. Buspirone exposure falls
5. Buspirone may become less effective

In one clinical study, rifampin reduced buspirone overall exposure by approximately 90%.

Carbamazepine, Phenytoin and Phenobarbital

These medications can increase CYP3A4 activity.

Examples include:

• Carbamazepine
• Phenytoin
• Phenobarbital They may therefore:

1. Increase buspirone metabolism
2. Reduce buspirone concentration
3. Potentially reduce its anti-anxiety effect.

• Alcohol Buspirone generally causes less sedation than benzodiazepines.

Nevertheless, prescribing information recommends avoiding alcohol because individual central nervous system effects can be unpredictable.

Dosage

Buspirone dosage is individualized according to:

• Anxiety symptoms
• Response to treatment
• Side effects
• Other medications
• Liver function
• Kidney function
• CYP3A4 drug interactions For Canadian patients, current product monographs generally recommend:

Starting dose

1. 5 mg two to three times daily
2. The dose may be increased by:

5 mg/day every 2–3 days

depending on response and tolerability.

Usual therapeutic dose

20–30 mg/day

divided into two or three doses.

Canadian maximum dose

45 mg/day in divided doses.

U.S. prescribing information differs slightly and permits a maximum of 60 mg/day, with an initial regimen of 7.5 mg twice daily.

Because this is a Canadian patient-facing page, I would use the Canadian 45 mg/day maximum as the primary information.

Should Buspirone Be Taken with Food?

Food affects the amount of buspirone absorbed.

The important point is consistency.

Patients should take buspirone: Always with food or Always without food rather than changing from day to day.

Food has been shown to increase buspirone exposure, so taking it consistently helps reduce variability in drug levels.

Tapering and Stopping Buspirone

Buspirone is different from benzodiazepines.

It does not generally produce physical dependence or a characteristic withdrawal syndrome.

Clinical studies have not found evidence of the same type of withdrawal associated with benzodiazepines, and one long-term study found no identifiable withdrawal syndrome after abrupt discontinuation following more than six months of treatment.

Therefore:

A prolonged taper is not routinely required for buspirone in the way it is for benzodiazepines.

However, patients should still discuss stopping buspirone with their healthcare professional.

Stopping treatment may result in:

• Return of anxiety
• Increased worry
• Restlessness
• Difficulty sleeping
• Other symptoms of the underlying anxiety disorder A clinician may sometimes choose to reduce the dose gradually, particularly after long-term treatment, to monitor whether anxiety symptoms return.

There is no universal buspirone tapering schedule appropriate for every patient.

Buspirone Is Not a Benzodiazepine Withdrawal Medication

This distinction is particularly important.

Someone taking lorazepam, clonazepam, alprazolam or another benzodiazepine can develop physical dependence.

Starting buspirone does not protect the patient from benzodiazepine withdrawal.

Therefore:

1. Benzodiazepine
2. Must be appropriately tapered when clinically necessary

Buspirone may be introduced as part of an anxiety-treatment strategy, but it should not be expected to prevent benzodiazepine withdrawal symptoms.

Buspirone and Pharmacogenomic Testing

Buspirone is metabolized primarily by:

CYP3A4

A simplified pathway is:

1. Buspirone
2. CYP3A4
3. Several metabolites, including 1-PP
4. Elimination

This makes CYP3A4 extremely important for drug interactions.

However, CYP3A4 differs from pharmacogenes such as CYP2D6 and CYP2C19.

There is currently no established CYP3A4 genotype-based buspirone dosing guideline.

In other words, current clinical pharmacogenomic guidelines do not allow a healthcare professional to reliably prescribe a buspirone dose simply from a CYP3A4 genetic result.

For buspirone, factors such as:

• CYP3A4 inhibitors
• CYP3A4 inducers
• Liver function
• Kidney function
• Food
• Other medications currently have greater established clinical importance for drug exposure.

Can Pharmacodynamic Genes Influence Buspirone Response?

Buspirone’s primary pharmacodynamic target is 5-HT1A encoded by the HTR1A gene. Genetic variation in HTR1A and other serotonin-related pathways has been investigated in anxiety, depression and medication response.

Buspirone also has some affinity for dopamine D2 receptors, encoded by DRD2.

These pathways may be biologically relevant to individual response.

However:

There are currently no established HTR1A- or DRD2-based buspirone prescribing guidelines.

Such pharmacodynamic information should therefore be interpreted cautiously and should not be presented as a validated method for determining buspirone dose or guaranteeing treatment response.

Frequently Asked Questions

Is Buspirone the Same as BuSpar?

Yes. BuSpar was the original well-known brand name for buspirone.

The brand has been discontinued in Canada and the United States, but generic buspirone remains available.

Is Buspirone an Antidepressant?

No. Buspirone is primarily classified as an anxiolytic, or anti-anxiety medication.

However, because it affects serotonin signaling, it is sometimes used together with antidepressants in selected patients.

Is Buspirone an SSRI?

No. SSRIs primarily block the serotonin transporter (SERT).

Buspirone works mainly by acting directly on 5-HT1A serotonin receptors.

Is Buspirone a Benzodiazepine?

No. Buspirone is not chemically or pharmacologically related to benzodiazepines.

It does not primarily act on GABA receptors and generally has much lower potential for sedation, dependence and abuse.

Does Buspirone Work Immediately for Anxiety?

Usually not. Buspirone must generally be taken regularly, and meaningful improvement may take several weeks.

It is therefore not usually used like a benzodiazepine for immediate relief of an acute panic or anxiety episode.

What Does Buspirone Do to Serotonin?

Buspirone acts primarily as a partial agonist at serotonin 5-HT1A receptors.

Rather than simply increasing serotonin concentration, it modifies how serotonin signaling is regulated within certain brain pathways.

Does Buspirone Affect Dopamine?

Yes, to some degree. Buspirone has moderate affinity for dopamine D2 receptors, although its primary anti-anxiety action is thought to involve serotonin 5-HT1A signaling.

Does Buspirone Make you Sleepy?

It can, but buspirone is generally less sedating than benzodiazepines.

Some people instead experience nervousness, restlessness or difficulty sleeping.

Does Buspirone Cause Weight Gain?

Weight gain is not among the most characteristic common side effects of buspirone.

Individual changes in weight can still occur for many reasons during treatment.

Does Buspirone Cause Sexual Side Effects?

Buspirone generally has a different sexual side-effect profile from SSRIs.

It is not commonly associated with the same degree of sexual dysfunction seen with some serotonergic antidepressants, although individual responses vary.

Can Buspirone Be Taken with an SSRI?

Yes, in some patients. Buspirone is sometimes combined with an SSRI or another antidepressant. Because both medications can influence serotonin signaling, the combination should be prescribed and monitored appropriately because of the potential for serotonin syndrome.

Can Buspirone Be Taken with Bupropion?

The combination may be prescribed in some circumstances. Bupropion does not strongly inhibit CYP3A4, so the major metabolic interaction seen with strong CYP3A4 inhibitors is not expected.

However, all psychiatric medications should still be reviewed together for clinical effects, side effects and other drug interactions.

Can I Drink Grapefruit Juice with Buspirone?

Large amounts should generally be avoided.

Grapefruit can inhibit CYP3A4 and markedly increase buspirone concentrations.

Why Should Buspirone Be Taken the Same Way with Food?

Food changes buspirone absorption.

Taking each dose consistently either with food or without food helps make drug exposure more predictable.

Does Buspirone Cause Addiction?

Buspirone has very low abuse and dependence potential compared with benzodiazepines.

Clinical and preclinical studies have not shown evidence of typical physical or psychological dependence.

Does Buspirone Need to Be Tapered?

Usually, it does not require the type of prolonged taper used for benzodiazepines.

Buspirone has not shown a characteristic physical withdrawal syndrome.

However, anxiety can return when treatment is discontinued, so stopping the medication should still be discussed with the prescribing healthcare professional.

Which Liver Enzyme Metabolizes Buspirone?

The most important liver enzyme is: CYP3A4

Strong CYP3A4 inhibitors can substantially increase buspirone concentrations, while CYP3A4 inducers can substantially reduce them.

Can Genetics Affect Buspirone Metabolism?

Genetic variation can contribute to differences in drug metabolism, but there is currently no established CYP3A4 pharmacogenomic dosing guideline for buspirone.

For buspirone, medication interactions involving CYP3A4 currently have much stronger established clinical importance than CYP3A4 genetic testing.

Can Buspirone Fail Even if It Is Metabolized Normally?

Yes. Normal metabolism only tells us that drug exposure may be appropriate.

Buspirone must also produce an effective response within serotonin and other neural pathways.

In simple terms:

PK — Pharmacokinetics

1. How does the body handle buspirone?
2. CYP3A4 metabolism
3. Appropriate drug exposure
4. PD — Pharmacodynamics
5. How does the brain respond?
6. 5-HT1A receptor signaling
7. Anxiety symptoms may improve

Normal PK does not automatically mean optimal PD response.

Can Pharmacogenomic Testing Tell Me Whether Buspirone Will Work?

No. There is currently no validated genetic test that can guarantee whether buspirone will relieve anxiety.

Medication response depends on many factors, including:

• Symptoms
• Diagnosis
• Drug exposure
• Other medications
• CYP3A4 interactions
• Liver and kidney function
• Serotonin signaling
• Individual brain biology
• Previous medication response Pharmacogenomic information should therefore be considered one part of personalized prescribing rather than a stand-alone answer.

Why Pharmacogenomic Testing May Matter

For buspirone, pharmacogenomics is less established for dosing than it is for medications such as atomoxetine or aripiprazole.

The most important established metabolic pathway is:

1. Buspirone
2. CYP3A4
3. Drug concentration

But current clinical practice places greater emphasis on:

• CYP3A4 drug interactions
• Liver and kidney function
• Other medications than on CYP3A4 genotype.

On the pharmacodynamic side:

1. Buspirone
2. 5-HT1A receptor
3. Serotonin signaling changes
4. Anxiety response

Genes involved in serotonin signaling may eventually help explain differences in response, but this area remains less clinically established.

The Bottom Line

Buspirone is a non-benzodiazepine anti-anxiety medication used primarily for generalized anxiety disorder.

Buspirone generally:

• Does not work immediately

• Causes less sedation than benzodiazepines

• Has low abuse and dependence potential

• Is primarily metabolized by CYP3A4

• Can have major interactions with CYP3A4 inhibitors and inducers References

• [https://health-products.canada.ca/dpd-bdpp/search-fast-recherche-rapide?lang=eng&no=0116263001&wbdisable=true&no=0116263001&wbdisable=true)

• [https://www.drugs.com/tips/buspar-patient-tips)

• https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9fc7091-b3ce-45fd-8d89-aeebdd81c327

• https://pubmed.ncbi.nlm.nih.gov/2406933/

• [https://pdf.hres.ca/dpd_pm/00050664.PDF)